Comirnaty Unione Europea - italiano - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccini - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

Spikevax (previously COVID-19 Vaccine Moderna) Unione Europea - italiano - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccini - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

SINGLE USE SUCTION TUBES Italia - italiano - Ministero della Salute

single use suction tubes

single use surgical ltd - cannule di aspirazione

Betoptic-S Single Dose Augentropfensuspension Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

betoptic-s single dose augentropfensuspension

medius ag - betaxololum - augentropfensuspension - betaxololum 2.5 mg ut betaxololi hydrochloridum, natrii polystyrensulfonas, carbomerum 974p, mannitolum, acidum hydrochloridum aut natrii hydroxidum, aqua, ad suspensionem pro 1 ml. - il glaucoma - synthetika

SINGLE-TIPPED PCL BLADE Italia - italiano - Ministero della Salute

single-tipped pcl blade

omni-tract surgical, a division of minnesota scientific, inc - divaricatori e retrattori per chirurgia generale - altri

SINGLE-STEP DILATOR, 10 FR, 5/BOX Italia - italiano - Ministero della Salute

single-step dilator, 10 fr, 5/box

gyrus acmi inc - trequarti (non ricompresi nel gruppo a)

SINGLE-USE POUCHES Italia - italiano - Ministero della Salute

single-use pouches

smiths medical md., inc. - strumentazione per l'infusione - componenti accessori hardware

SINGLEPORT ADAPTER, PHOTON Italia - italiano - Ministero della Salute

singleport adapter, photon

synergetics inc. - strumentazione per acquisizione e gestione di immagini endoscopiche e di chirurgia mini-invasiva - componenti accessori hardware

SINGLE-VALVE ASPIRATOR Italia - italiano - Ministero della Salute

single-valve aspirator

womancare global - strumentazione per ginecologia e materno-infantile non altrimenti classificata

SINGLE-USE COLLECTING CONTAINER 2L P/25 Italia - italiano - Ministero della Salute

single-use collecting container 2l p/25

medicon eg - dispositivi da somministrazione, prelievo e raccolta - altri